Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$833.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
No filings held for this insider can be measured against the deadline.
The 14 most recent Form 4 transactions.
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,263 | $94.75 | $214.4K | -0.9% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,237 | $93.85 | $209.9K | -0.9% | Open the original filing on SEC.gov |
| Jul 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.1% | Open the original filing on SEC.gov |
| Jun 15 | ORKA | Oruka Therapeutics, Inc. | SSELL | 600 | $69.69 | $41.8K | -0.3% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 100 | $68.48 | $6.8K | <0.1% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 200 | $67.16 | $13.4K | <0.1% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 400 | $66.06 | $26.4K | -0.2% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 300 | $65.10 | $19.5K | -0.1% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,800 | $64.15 | $115.5K | -0.8% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,200 | $62.58 | $137.7K | -0.9% | Open the original filing on SEC.gov |
| May 1 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,000 | $7.80 | $39K | +2.1% | Open the original filing on SEC.gov |